Alexa Fluor® 568 Anti-Smad4 抗体 [EP618Y]
Alexa Fluor® 568 Anti-Smad4 antibody [EP618Y]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal SMAD4 antibody - conjugated to Alexa Fluor® 568.
別名を表示する
DPC4, MADH4, SMAD4, Mothers against decapentaplegic homolog 4, MAD homolog 4, Mothers against DPP homolog 4, Deletion target in pancreatic carcinoma 4, SMAD family member 4, SMAD 4, Smad4, hSMAD4
関連する標識済み抗体及び組成の異なる製品 (8)
-
Anti-Smad4 antibody [EP618Y]
-
Anti-Smad4 antibody [EP618Y] - BSA and Azide free
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Smad4 antibody [EP618Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Smad4 antibody [EP618Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Smad4 antibody [EP618Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Smad4 antibody [EP618Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Smad4 antibody [EP618Y]
-
HRP Anti-Smad4 antibody [EP618Y]
製品の詳細
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Smad4 influences cell proliferation differentiation and apoptosis by mediating signals from TGF-beta cytokines. It is part of the Smad protein family acting as a transcriptional controller. Upon TGF-beta receptor activation Smad4 forms complexes with Smad2 and Smad3 translocating to the nucleus to regulate genes imperative for cellular homeostasis. Its role in cell cycle regulation underlines its contribution to normal cellular functions and its potential involvement in disorders.
Pathways
Smad4 operates within the TGF-beta pathway linking extracellular signals to nuclear transcription alterations. It participates in the regulation of epithelial-mesenchymal transition (EMT) a process important for development and tumor progression. In these pathways Smad4 interacts closely with Smad2 and Smad3 orchestrating various cellular responses to external stimuli through transcriptional management.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com